Kline Ashley Hartmann
SEC insider (Form 3/4/5 filer). CIK 0002071433. Chief Commercial Officer at PALVELLA THERAPEUTICS, INC. (PVLA). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 5, 2026. Located in WAYNE, PA.
Companies Kline Ashley Hartmann has filed insider reports for
- PALVELLA THERAPEUTICS, INC. (PVLA): Officer, Chief Commercial Officer
Kline Ashley Hartmann
CIK: 0002071433
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PALVELLA THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 5, 2026PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectStock Option (Right to Buy)
38.5K shares- - May 27, 2025PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectIncentive Stock Option (right to buy)
17.4K shares- - May 27, 2025PVLA
PALVELLA THERAPEUTICS, INC.
AwardDirectNon-Qualified Stock Option (right to buy)
111.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 5, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Award Stock Option (Right to Buy) | 38,517 | - | - | Direct |
| May 27, 2025 | PVLA PALVELLA THERAPEUTICS, INC. | Award Incentive Stock Option (right to buy) | 17,436 | - | - | Direct |
| May 27, 2025 | PVLA PALVELLA THERAPEUTICS, INC. | Award Non-Qualified Stock Option (right to buy) | 111,496 | - | - | Direct |
1-3 of 3 transactions